Vendor, La Jolla, CA
J. Craig Venter Institute, Inc.
UEI FL8UNYTG72D1, CAGE 3YFD9
4 awards and $1,718,350 obligated between July 8, 2024 and June 30, 2026, 75% under full and open competition, against 37.8 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Centers for Disease Control and Prevention | $2,334,513 |
| National Institutes of Health | $0 |
| Defense Health Agency | -$266,824 |
| Defense Advanced Research Projects Agency | -$349,339 |
Industries
NAICS on the awards, by dollars.
| Testing Laboratories and ServicesNAICS 541380 | $2,334,513 |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$266,824 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$349,339 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
| Competed Under SAP | 1 |
| Purchase Order | 2 |
| Definitive Contract | 1 |
Hear when J. Craig Venter Institute, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of J. Craig Venter Institute, Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling testing laboratories and services to Centers for Disease Control and Prevention, by dollars.
| Ginkgo Bioworks, Inc.Boston, MA | $120,345,607 |
| Verily Health Inc.Coppell, TX | $38,215,087 |
| Bureau Veritas North America Inc.Novi, MI | $1,093,576 |
| GT Molecular, Inc.Fort Collins, CO | $1,029,779 |
| Eurofins Environment Testing Northern California LLCWest Sacramento, CA | $454,663 |
| Bioplastics/Cyclertest Inc.Durham, NC | $96,470 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30123P17712Purchase Order, July 8, 2024, Full and Open Competition, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Rapid Synthesis of Plasmids and MutagensisNAICS 541380, PSC Q301 | $2,334,513 |
| HHSN268201600035IAugust 22, 2024, Full and Open Competition, 10 offers | National Institutes of Health NhlbiNational Institutes of Health | Centralized Omics Resource (Core)NAICS 541380, PSC B599 | $0 |
| W81XWH18P0223Purchase Order, August 22, 2024, Competed Under SAP, 2 offers | Army Med Res Acq ActivityDefense Health Agency | Genetic Sequencing of Dehisced WoundsNAICS 541715, PSC AN17 | -$266,824 |
| HR001119C0069Definitive Contract, March 10, 2025, Full and Open Competition, 138 offers | Def Advanced Research Projects AgcyDefense Advanced Research Projects Agency | Task 5NAICS 541714, PSC AD92 | -$349,339 |
- Places of performance
- CaliforniaGeorgia
- Product and service codes
- Q301 Reference Laboratory TestingB599 Other Special Studies and AnalysisAN17 N – Health R&D ServicesAD92
- Transactions
- 10 across 4 awards